Cargando…

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis

We investigated the prognostic value of a range of histologic parameters in medullary thyroid carcinoma (MTC) to design a grading system to predict overall survival. We assessed 76 patients with MTCs undergoing primary tumor resection for age, sex, tumor size, vascular space invasion, lymph node met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fuchs, Talia L., Nassour, Anthony J., Glover, Anthony, Sywak, Mark S., Sidhu, Stan B., Delbridge, Leigh W., Clifton-Bligh, Roderick J., Gild, Matti L., Tsang, Venessa, Robinson, Bruce G., Clarkson, Adele, Sheen, Amy, Sioson, Loretta, Chou, Angela, Gill, Anthony J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641183/ https://www.ncbi.nlm.nih.gov/pubmed/32452872 http://dx.doi.org/10.1097/PAS.0000000000001505

Ejemplares similares

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma
por: Kesby, Nicholas, et al.
Publicado: (2023)

Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update
por: Worrall, Benjamin J, et al.
Publicado: (2023)

Medullary Thyroid Cancer: Updates and Challenges
por: Gild, Matti L, et al.
Publicado: (2023)

Molecular Markers Guiding Thyroid Cancer Management
por: Nylén, Carolina, et al.
Publicado: (2020)

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
por: Tsang, Venessa, et al.
Publicado: (2022)

Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer
por: White, Eleanor, et al.
Publicado: (2023)

Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil
por: Lin, Mike, et al.
Publicado: (2020)

A Clinicopathologic and Molecular Analysis of Fumarate Hydratase–deficient Pheochromocytoma and Paraganglioma
por: Fuchs, Talia L., et al.
Publicado: (2023)

Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types()
por: Kim, Edward, et al.
Publicado: (2016)

A Detailed Clinicopathologic Study of ALK-translocated Papillary Thyroid Carcinoma
por: Chou, Angela, et al.
Publicado: (2015)

Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
por: Cuylen, Sara, et al.
Publicado: (2016)

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
por: Gill, Anthony J., et al.
Publicado: (2019)

Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas
por: Gill, Anthony J., et al.
Publicado: (2014)

TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas
por: Bullock, Martyn, et al.
Publicado: (2016)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery
por: Booth, Daniel G, et al.
Publicado: (2014)

Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors
por: KEMMERLING, RALF, et al.
Publicado: (2014)

Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
por: Gild, Matti L, et al.
Publicado: (2022)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

The Ki-67 and RepoMan mitotic phosphatases assemble via an identical, yet novel mechanism
por: Kumar, Ganesan Senthil, et al.
Publicado: (2016)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology
por: Andrici, Juliana, et al.
Publicado: (2015)

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas
por: Duregon, Eleonora, et al.
Publicado: (2016)

Can Histological Grade and Mitotic Index Replace Ki67 to Determine Luminal Breast Cancer Subtypes?
por: Oddó, David, et al.
Publicado: (2018)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Immune Related Adverse Events of the Thyroid – A Narrative Review
por: Muir, Christopher A., et al.
Publicado: (2022)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Sonographic Volumetric Assessment Is a More Accurate Measure Than Maximum Diameter Alone in Papillary Thyroid Cancer
por: Pennington, Thomas E, et al.
Publicado: (2018)

Thyroid Hormone Abuse Among Elite Athletes
por: Handelsman, David J, et al.
Publicado: (2023)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer
por: Aziz, Sura, et al.
Publicado: (2016)

The p150N domain of chromatin assembly factor-1 regulates Ki-67 accumulation on the mitotic perichromosomal layer
por: Matheson, Timothy D., et al.
Publicado: (2017)

Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot
por: Beelen, Karin, et al.
Publicado: (2018)

Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer
por: Ning, Jing, et al.
Publicado: (2019)

The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
por: Clifton-Bligh, Roderick J.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p8sko7g4lbp2629u98fcjr6gn7